202 reports of this reaction
4.3% of all METHYLENE BLUE reports
#4 most reported adverse reaction
HYPOTENSION is the #4 most commonly reported adverse reaction for METHYLENE BLUE, manufactured by American Regent, Inc.. There are 202 FDA adverse event reports linking METHYLENE BLUE to HYPOTENSION. This represents approximately 4.3% of all 4,684 adverse event reports for this drug.
Patients taking METHYLENE BLUE who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTENSION is moderately reported among METHYLENE BLUE users, representing a notable but not dominant share of adverse events.
In addition to hypotension, the following adverse reactions have been reported for METHYLENE BLUE:
The following drugs have also been linked to hypotension in FDA adverse event reports:
HYPOTENSION has been reported as an adverse event in 202 FDA reports for METHYLENE BLUE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTENSION accounts for approximately 4.3% of all adverse event reports for METHYLENE BLUE, making it a notable side effect.
If you experience hypotension while taking METHYLENE BLUE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.